LAURA TUDOR: Open Payments
NPI 1790709236 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 21 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Eisai Inc. | 2 | $42 |
| ARGENX US, INC. | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| TG Therapeutics, Inc. | 2 | $30 |
| UCB, Inc. | 1 | $28 |
| Medtronic, Inc. | 1 | $28 |
| Neurelis, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
Products named: FYCOMPA, HYQVIA, Leqembi, ACTHAR, BRIUMVI, Rystiggo, DUET, VALTOCO.
Industry payments across KY — which companies pay providers there.
